TABLE 2.
Lab services performed on site in respondents’ primary institutiona
| Procedure | No. (%) with response |
||
|---|---|---|---|
| Available onsite | Offsite only | Not sure/not answered | |
| Gram stain interpretation, Monday through Friday, 8 a.m.–3 p.m. | 491 (91) | 25 (5) | 24 (4) |
| Blood culture bottle processing | 476 (88) | 44 (8) | 20 (4) |
| C. difficile testing (e.g., GDH, NAAT) | 453 (84) | 50 (9) | 37 (7) |
| Identification and susceptibility testing of sterile-site isolates | 429 (80) | 60 (11) | 51 (9) |
| Respiratory virus panel testing (e.g., RSV, influenza) | 421 (78) | 63 (12) | 56 (10) |
| Blood smears for infection (e.g., malaria, Anaplasma, Ehrlichia) | 403 (75) | 64 (12) | 73 (13) |
| Gram stain interpretation, Monday through Friday, 11 p.m.–6 a.m. | 399 (74) | 37 (7) | 104 (19) |
| AFB stains and culture | 338 (63) | 105 (19) | 97 (18) |
| GI pathogen panel (e.g., Salmonella, norovirus) | 335 (62) | 94 (17) | 111 (21) |
| Blood culture rapid ID (e.g., BioFire, Verigene) | 331 (61) | 90 (17) | 119 (22) |
| Legionella urinary antigen | 327 (61) | 97 (18) | 116 (21) |
| MALDI-TOF identification system for bacteriology | 270 (50) | 121 (22) | 149 (28) |
| NAAT for Mycobacterium tuberculosis | 231 (43) | 158 (29) | 151 (28) |
a
n = 540. GDH, glutamate dehydrogenase; NAAT, nucleic acid amplification testing; RSV, respiratory syncytial virus; AFB, acid-fast bacillus; GI, gastrointestinal.